Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × ponatinib × Sarcoma × Clear all

Phase

Status

Unknown 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 4 Myeloid 3 Gastrointestinal 2 Thoracic 1 Sarcoma 1 Lymphoid 1 Breast 1

Conditions

Gastrointestinal Stromal Tumors 1

Interventions

Doxorubicin 20 Radiotherapy 15 Cyclophosphamide 15 apatinib 14 Ifosfamide 12 anlotinib 11 Temozolomide 9 Imatinib Mesylate 9 Vincristine 8 camrelizumab 7 Surgical Procedures, Operative 7 Drug Therapy 7 Methotrexate 6 Neoadjuvant Therapy 5 Dactinomycin 5 fludarabine phosphate 4 Paclitaxel 4 Etoposide 4 Docetaxel 4 Carboplatin 4 toripalimab 3 pembrolizumab 3 Trabectedin 3 Topotecan 3 Surveys and Questionnaires 3 Radiation Dose Hypofractionation 3 Nivolumab 3 Melphalan 3 Laparoscopy 3 Irinotecan 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03171389 2017-05-31

POETIG

Universität Duisburg-Essen

Phase 2 Unknown

GastrointestinalSarcoma

Gastrointestinal Stromal Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡